BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Salvadori M, Tsalouchos A. Hepatitis C and renal transplantation in era of new antiviral agents. World J Transplant 2018; 8(4): 84-96 [PMID: 30148074 DOI: 10.5500/wjt.v8.i4.84]
URL: https://www.wjgnet.com/1007-9327/full/v8/i4/84.htm
Number Citing Articles
1
Kasra Ghanaat, Heidar Sharafi, Seyed Moayed Alavian. The Efficacy and Safety of Sofosbuvir/Daclatasvir Fixed-Dose Combination in Iranian Hemodialysis Patients with Hepatitis C Virus InfectionNephro-Urology Monthly 2021; 13(2) doi: 10.5812/numonthly.114049
2
Muhammad Umair Khan, Mohamed Ibrahim Mahmoud, Adeel A. Butt. Hepatitis c virus and chronic kidney diseaseExpert Review of Gastroenterology & Hepatology 2020; 14(7): 579 doi: 10.1080/17474124.2020.1776111
3
Manisha Thakur, Anurag Chauhan, Prashant Jambunathan, Shikha Awasthi, Thilagavathi K, Mujeeb VR. EFFICACY OF SOFOSBUVIR AND DACLATASVIR IN COMPENSATED CHRONIC HEPATITIS C INFECTION: A SINGLE CENTER, OPEN-LABEL AND PROOF OF CONCEPT STUDYGLOBAL JOURNAL FOR RESEARCH ANALYSIS 2021; : 27 doi: 10.36106/5009819
4
Ignacio García-Juárez. Trasplante renal en el receptor del virus de la hepatitis C positivoRevista Mexicana de Trasplantes 2020; 9(S1): 127 doi: 10.35366/93503
5
Antonella Santonicola, Giancarlo Bilancio, Fabiana Zingone, Laura Donnarumma, Cesare Caputo, Carolina Ciacci, Niccola Funel. The Psychosocial Burden of HCV Infection and the Impact of Antiviral Therapy on the Quality of Life in Liver and Kidney Transplant Recipients: A Pilot StudyGastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/8754247